Research Article

High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients

Table 2

Characteristics of HD patients with and without plaque.

ItemsHD/nonplaque group HD/plaque group t/χ2 valueP value

Age, years0.7730.440
Gender, male/female32/2830/230.0820.774
Dialysis duration, months44.5 ± 30.80.7870.432
Smoking, no. (%)16 (26.7)14 (26.4)0.1810.671
Diabetes, no. (%)11 (18.3)10 (18.9)1.0640.302
NLR14.4840.000
KT/V0.2930.770
Hb, g/L0.8400.402
Alb, g/L0.4380.662
ALT, U/L0.7790.437
AST, U/L0.9400.348
TG, mmol/L1.1410.255
Tch, mmol/L1.5610.120
LDL-C, mmol/L0.4660.642
hsCRP, mmol/L11.9580.000
Cr, mol/L0.3720.710
BUN, mmol/L0.5880.557
Ca, mmol/L0.5130.608
P, mmol/L1.0230.307
iPTH, pg/ml0.5900.556
RASI, no. (%)43 (71.7)42 (79.2)0.2850.593
CCB, no. (%)45 (75.0)43 (81.1)0.6910.406
β-Blocker, no. (%)17 (28.3)17 (32.1)2.3250.127

Values are means ± SD, unless specified otherwise.
, compared with HD/nonplaque group.
NLR: neutrophil to lymphocyte ratio; Hb: hemoglobin; Alb: albumin; ALT: alanine transaminase; AST: aspartate aminotransferase; TG: triglyceride; Tch: total cholesterol; LDL-C: low density lipoprotein-cholesterol; hsCRP: high sensitivity C reactive protein; Cr: creatinine; BUN: blood urea nitrogen; Ca: calcium; P: phosphorus; iPTH: intact parathyroid hormone; RASI: renin angiotensin system inhibitor; CCB: calcium channel blocker; β-blocker: β-receptor blocker.